Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

EV01: A phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium

18 Apr 2008

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hepatitis B Virus Studies
Share to HIV/AIDS drug development and treatment
Share to HIV Research and Treatment

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 18502002
DOI: 10.1016/j.vaccine.2008.03.083

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

EV01: A phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc ConsortiumPMID 18502002Read ↗

Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteersSemantic proximity Read ↗

HIV/AIDS Vaccines: 2018.Semantic proximity Read ↗

[HIV vaccine].Semantic proximity Read ↗

Safety and broad immunogenicity of HIVconsvX conserved mosaic candidate T-cell vaccines vectored by ChAdOx1 and MVA in HIV-CORE 006: a double-blind, randomised, placebo-controlled phase 1 trial in healthy adults living without HIV-1 in eastern and southern AfricaSemantic proximity Read ↗

Placebocontrolled Phase 3 Trial of a Recombinant Glycoprotein 120 Vaccine to Prevent HIV-1 InfectionSemantic proximity Read ↗

Recent strategies targeting HIV glycans in vaccine designSemantic proximity Read ↗

[Advances in AIDS vaccines].Semantic proximity Read ↗

A Phase IV, open-label, single-arm, multicentric clinical trial for evaluation of Human Papillomavirus 9vHPV vaccine immunogenicity in Men Who Have Sex with Men living with HIV: GeSIDA Study 10017Semantic proximity Read ↗

Translational research insights from completed HIV vaccine efficacy trials.Semantic proximity Read ↗

Assessment of HIV vaccine development: past, present, and future.Semantic proximity Read ↗

First clinical study of germline-targeting strategy: One step closer to a successful bnAb-based HIV vaccineSemantic proximity Read ↗

Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccineSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.